SYBX

Synlogic (SYBX)

About Synlogic (SYBX)

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.

Details

Daily high
$1.31
Daily low
$1.25
Price at open
$1.30
52 Week High
$1.96
52 Week Low
$1.15
Market cap
15.2M
Dividend yield
0.00%
Volume
6,589
Avg. volume
6,458
P/E ratio
-.52

Synlogic News

Details

Daily high
$1.31
Daily low
$1.25
Price at open
$1.30
52 Week High
$1.96
52 Week Low
$1.15
Market cap
15.2M
Dividend yield
0.00%
Volume
6,589
Avg. volume
6,458
P/E ratio
-.52